Inovio Pharmaceuticals, Inc. · NASDAQ:INO

Sumner Michael John exercised options for 2,385 Inovio Pharmaceuticals, Inc. shares (Form 4)

Traded May 15, 2026 · Filed May 18, 2026

On May 15, 2026, Sumner Michael John (Chief Medical Officer) exercised options for 2,385 Inovio Pharmaceuticals, Inc. shares, leaving 35,281 shares. Filed May 18, 2026 (Form 4).

Options exercised
2,385 shares
Holding after
35,281 shares
Trading plan
No
Role
Chief Medical Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 15, 2026Common StockOption exercise2,38535,961Direct
May 15, 2026Common StockShares withheld for tax680US$1.3035,281Direct

Source

View original at SEC

Related